Opaleye Management Inc. bought a new stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 167,500 shares of the company’s stock, valued at approximately $3,373,000. Zentalis Pharmaceuticals comprises about 1.2% of […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating) had its price target cut by equities research analysts at Jefferies Financial Group from $120.00 to $70.00 in a research report issued to clients and investors on Friday, The Fly reports. Jefferies Financial Group’s price objective points to a potential upside of 162.27% from the stock’s current price. A […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) shares were down 4.9% during mid-day trading on Monday . The stock traded as low as $21.17 and last traded at $21.20. Approximately 62,734 shares traded hands during trading, a decline of 89% from the average daily volume of 588,935 shares. The stock had previously closed at $22.29. […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) rose 3.6% on Wednesday . The company traded as high as $18.28 and last traded at $18.12. Approximately 284,046 shares changed hands during trading, a decline of 49% from the average daily volume of 559,839 shares. The stock had previously closed at $17.49. Wall Street Analysts […]